HPd1 Antibody (DHIC2-4A10) - BSA Free

Immunocytochemistry/Immunofluorescence: HPd1 Antibody (DHIC2-4A10) [NBP1-18953] - Immunofluorescence on frozen section of human pancreas.

Flow Cytometry: HPd1 Antibody (DHIC2-4A10) [NBP1-18953] - Analysis of enzyme dispersed human pancreas cells.

• Reactivity: Hu
• Applications: WB, Flow, ICC/IF, IHC
• Clone: DHIC2-4A10
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: Unconjugated
• Format: BSA Free
• Concentration: This product is unpurified. The exact concentration of antibody is not quantifiable.

HPd1 Antibody (DHIC2-4A10) - BSA Free Summary

• Description: Novus Biologicals Mouse HPd1 Antibody (DHIC2-4A10) - BSA Free (NBP1-18953) is a monoclonal antibody validated for use in IHC, WB, Flow and ICC/IF. Anti-HPd1 Antibody: Cited in 4 publications. All Novus Biologicals antibodies are covered by our 100% guarantee.
• Immunogen: Human pancreatic enriched duct cells
• Localization: Cell surface
• Marker: Pancreatic, liver duct cell Marker
• Specificity: Specific for duct cell types.
• Isotype: IgG1
• Clonality: Monoclonal
• Host: Mouse
• Purity: Tissue culture supernatant

Applications/Dilutions

• Dilutions:
  • Flow Cytometry 1:50-1:100
  • Immunocytochemistry/ Immunofluorescence 1:10-1:500
  • Immunohistochemistry 1:100
  • Immunohistochemistry-Frozen 1:100
  • Western Blot 1:100-1:2000
• Application Notes: This HPd1 (DHIC2-4A10) antibody is useful for Immunohistochemistry on acetone fixed frozen sections, Immunocytochemistry/Immunofluorescence, Flow cytometry and Western blot.

Packaging, Storage & Formulations

• Storage: Store at 4C. Do not freeze.
• Buffer: Tissue culture supernatant
• Preservative: 0.09% Sodium Azide
• Concentration: This product is unpurified. The exact concentration of antibody is not quantifiable.
• Purity: Tissue culture supernatant

Alternate Names for HPd1 Antibody (DHIC2-4A10) - BSA Free

• DHIC2-4A10
• HPd1
• human pancreatic duct cell

Background

Stem cells offer a therapeutic promise for many diseases. In the case of diabetes, stem cells offer the promise that beta cells may be generated ex vivo for the possible transplantation and cure of Type I diabetes (Couri CE, et al.). For this to happen, stem cells will need to be isolated and expanded, they will need to be differentiated toward the beta cell lineage, and the differentiated cell progeny used for transplantation may need to be isolated from complex cell mixtures following differentiation. Appropriate markers targeting cell surface molecules on developing and mature pancreatic cells will be required for such research.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Publications for HPd1 Antibody (NBP1-18953)(4)

Publications using NBP1-18953

• Jakel C, Bergmann F, Toth R et al. Genome-wide genetic and epigenetic analyses of pancreatic acinar cell carcinomas reveal aberrations in genome stability Nat Commun. 2017-11-06 [PMID: 29109526] (Human)
• Nostro MC, Sarangi F, Ogawa S et al. Pancreatic differentiation 2008-01-01 [PMID: 23658992]
• Dorrell C, Schug J, Lin C et al. Transcriptomes of the major human pancreatic cell types. Diabetologia. 2011-01-01 [PMID: 21882062]
• Dorrell, et al. Isolation of major pancreatic cell types long-term culture-initiating cells using novel human surface markers. Stem Cell Rsch 1(3):183-194. 2008-01-01 [PMID: 19383399] (FLOW, IHC-Fr, Human)